Bioventus Inc. BVS

Company Overview

Bioventus Inc. is a U.S.-based medical technology company focused on developing and commercializing solutions that support active healing and musculoskeletal health. The company operates within the orthobiologics, bone stimulation, joint preservation, and pain treatment segments of the medical device industry. Its offerings are primarily used by orthopedic surgeons, sports medicine specialists, and other musculoskeletal healthcare providers to treat bone fractures, osteoarthritis, and soft tissue injuries.

The company’s primary revenue drivers are non-invasive bone growth stimulators, joint preservation products, and minimally invasive pain management technologies. Bioventus is positioned as a mid-sized, innovation-driven player with a portfolio that spans biologics, medical devices, and digital-enabling technologies. Founded in 2012 through the spinout of orthobiologics assets from Smith & Nephew, the company has expanded organically and through acquisitions, completing its initial public offering in 2021 and continuing to evolve as a publicly traded entity.